There is significant individual variability in cognitive decline during aging, suggesting the existence of ''vulnerability factors" for eventual deficits. Neuroinflammation may be one such factor; increased glial reactivity is a common outcome of aging, which in turn is associated with numerous neurodegenerative conditions. Early-life infection leads to cognitive impairment in conjunction with an inflammatory challenge in young adulthood, which led us to explore whether it might also accelerate the cognitive decline associated with aging. Rats were treated on postnatal day 4 with PBS or Escherichia coli, and then tested for learning and memory at 2 or 16 months of age, using two fear-conditioning tasks (context pre-exposure and ambiguous cue), and a spatial water maze task. Neonatally-infected rats exhibited memory impairments in both the ambiguous cue fear-conditioning task and in the water maze, but only at 16 months. There were no differences in anxiety between groups. Neonatally-infected rats also exhibited greater aging-induced increases in glial markers (CD11b and MHC II on microglia, and GFAP on astrocytes), as well as selective changes in NMDA receptor subunit expression within the hippocampus, but not in amygdala or parietal cortex compared to controls. Taken together, these data suggest that earlylife infection leads to less successful cognitive aging, which may be linked to changes in glial reactivity.
Introduction
Cognitive decline is one of the primary consequences of aging. Deficits very often include specific impairments in hippocampaldependent learning and memory (Robitsek, Fortin, Koh, Gallagher, & Eichenbaum, 2008) . However, there is significant individual variability in cognitive decline during aging, as some individuals age more successfully than others, a phenomenon that has been well characterized in rodents (Lee, Min, Gallagher, & Kirkwood, 2005; Nicholson, Yoshida, Berry, Gallagher, & Geinisman, 2004) . Similarly, only a subset of the population will eventually develop dementias such as Alzheimer's disease, the risk factors for which are not well defined. Such variability suggests the existence of ''vulnerability factors" for eventual deficits.
Neuroinflammation may be one such factor. For instance, exaggerated microglial cell activation, the primary immune cells of the CNS, and associated increased cytokine expression are associated with virtually every characterized neurodegenerative condition, including Alzheimer's disease (Lynch, in press). However, neuroinflammatory changes are a component of normal aging, including major histocompatibility (MHC II) expression upregulation on microglia, astrogliosis, and increased expression of pro-inflammatory cytokines (e.g., interleukin [IL]-1b; Godbout and Johnson, 2009) which in turn influence neural function (e.g., long-termpotentiation (LTP); Lynch, in press). Thus, the factors that create a transition from normal to pathological within one individual, and not in another, remain unclear.
Many neuroinflammatory/neurodegenerative conditions are now widely believed to have a developmental component (Bilbo & Schwarz, 2009 ). The field of developmental or ''fetal programming" has emerged based on the idea that experience during the perinatal period may modulate or ''program" the normal course of development, with the result that adult outcomes are significantly and often permanently altered (Bennet & Gunn, 2006) . For instance, bacterial infection in neonatal rats is associated with cognitive dysfunction in adulthood. These impairments, however, are only observed if a peripheral immune challenge (lipopolysaccharide [LPS] ) is administered around the time of learning (Bilbo, Rudy, Watkins, & Maier, 2006; Bilbo et al., 2005a Bilbo et al., , 2005b Bilbo et al., , 2007 Bilbo et al., , 2008 . LPS is a potent inducer of cytokines within the brain, and exaggerated or prolonged expression of cytokines in response to the LPS may impair synaptic processes and hippocampal-dependent memories (Barrientos et al., 2002; Gibertini, Newton, Friedman, & Klein, 1995; Vereker, Campbell, Roche, McEntee, & Lynch, 2000) . Consistent with this possibility, neonatally-infected rats exhibit exaggerated microglial activation and IL-1b responses to LPS within the brain compared to control rats, and preventing the
